Androulla Elia

1.6k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Androulla Elia is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Androulla Elia has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Oncology. Recurrent topics in Androulla Elia's work include interferon and immune responses (6 papers), RNA regulation and disease (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Androulla Elia is often cited by papers focused on interferon and immune responses (6 papers), RNA regulation and disease (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Androulla Elia collaborates with scholars based in United Kingdom, France and Australia. Androulla Elia's co-authors include Michael J. Clemens, M J Clemens, Constantina Constantinou, Ken Laing, Ulrich‐Axel Bommer, Vivienne J. Tilleray, Rui Liu, Hua Tang, Christopher G. Proud and Bruno D. Fonseca and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Androulla Elia

21 papers receiving 1.3k citations

Hit Papers

The Double-Stranded RNA-D... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Androulla Elia United Kingdom 15 849 376 239 205 187 22 1.4k
Hirotada Kojima Japan 15 791 0.9× 663 1.8× 261 1.1× 225 1.1× 160 0.9× 18 1.4k
Ji‐Yang Wang Japan 22 663 0.8× 930 2.5× 232 1.0× 112 0.5× 162 0.9× 60 1.7k
Marcia Bellon United States 20 799 0.9× 575 1.5× 295 1.2× 133 0.6× 271 1.4× 28 1.6k
Yun You United States 18 640 0.8× 287 0.8× 389 1.6× 174 0.8× 72 0.4× 37 1.3k
Carmela DeLuca Canada 11 609 0.7× 654 1.7× 381 1.6× 179 0.9× 279 1.5× 12 1.4k
José Rivera Spain 16 911 1.1× 202 0.5× 194 0.8× 159 0.8× 53 0.3× 35 1.5k
Hsuan Liu Taiwan 22 1.1k 1.4× 199 0.5× 269 1.1× 211 1.0× 444 2.4× 69 1.9k
Simon Yu United States 11 474 0.6× 587 1.6× 233 1.0× 150 0.7× 93 0.5× 12 1.1k
Suzana Marušić United States 17 495 0.6× 789 2.1× 235 1.0× 100 0.5× 97 0.5× 26 1.5k
Takashi Mino Japan 19 994 1.2× 855 2.3× 258 1.1× 129 0.6× 531 2.8× 30 1.7k

Countries citing papers authored by Androulla Elia

Since Specialization
Citations

This map shows the geographic impact of Androulla Elia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Androulla Elia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Androulla Elia more than expected).

Fields of papers citing papers by Androulla Elia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Androulla Elia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Androulla Elia. The network helps show where Androulla Elia may publish in the future.

Co-authorship network of co-authors of Androulla Elia

This figure shows the co-authorship network connecting the top 25 collaborators of Androulla Elia. A scholar is included among the top collaborators of Androulla Elia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Androulla Elia. Androulla Elia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kraev, Igor, et al.. (2022). Extracellular Vesicles Inhibit the Response of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine and TRAIL Treatment. International Journal of Molecular Sciences. 23(14). 7810–7810. 7 indexed citations
2.
Elia, Androulla, et al.. (2017). Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL. Cell Death and Disease. 8(12). 3204–3204. 12 indexed citations
3.
Elia, Androulla, Ian Powley, Marion MacFarlane, & Michael J. Clemens. (2014). Modulation of the Sensitivity of Jurkat T-Cells to Inhibition of Protein Synthesis by Tumor Necrosis Factor α-Related Apoptosis-Inducing Ligand. Journal of Interferon & Cytokine Research. 34(10). 769–777. 1 indexed citations
4.
Elia, Androulla, et al.. (2014). DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1. Oncotarget. 6(1). 427–440. 47 indexed citations
5.
Clemens, Michael J., Androulla Elia, & Simon Morley. (2013). Requirement for the eIF4E Binding Proteins for the Synergistic Down-Regulation of Protein Synthesis by Hypertonic Conditions and mTOR Inhibition. PLoS ONE. 8(8). e71138–e71138. 5 indexed citations
6.
Rice, Suman, et al.. (2013). Metformin Inhibits Follicle-Stimulating Hormone (FSH) Action in Human Granulosa Cells: Relevance to Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 98(9). E1491–E1500. 53 indexed citations
7.
8.
Tzartos, John S., Gulfaraz Khan, Anna Vossenkämper, et al.. (2011). Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology. 78(1). 15–23. 109 indexed citations
9.
Bommer, Ulrich‐Axel, Amandine Perrin, Philip R. Dash, et al.. (2009). Roles of the translationally controlled tumour protein (TCTP) and the double-stranded RNA-dependent protein kinase, PKR, in cellular stress responses. Oncogene. 29(5). 763–773. 39 indexed citations
10.
Constantinou, Constantina, Androulla Elia, & Michael J. Clemens. (2008). Activation of p53 stimulates proteasome‐dependent truncation of eIF4E‐binding protein 1 (4E‐BP1). Biology of the Cell. 100(5). 279–289. 28 indexed citations
11.
Wang, Xuemin, Bruno D. Fonseca, Hua Tang, et al.. (2008). Re-evaluating the Roles of Proposed Modulators of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling. Journal of Biological Chemistry. 283(45). 30482–30492. 114 indexed citations
12.
Elia, Androulla, Constantina Constantinou, & M J Clemens. (2007). Effects of protein phosphorylation on ubiquitination and stability of the translational inhibitor protein 4E-BP1. Oncogene. 27(6). 811–822. 59 indexed citations
14.
Elia, Androulla, et al.. (2004). Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein‐Barr virus small RNA EBER‐1. European Journal of Biochemistry. 271(10). 1895–1905. 40 indexed citations
15.
Elia, Androulla, et al.. (2003). Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA. RNA. 9(7). 858–870. 49 indexed citations
16.
Laing, Ken, Androulla Elia, Ian W. Jeffrey, & Michael J. Clemens. (2003). Analysis of RNA-Protein Interactions of the EBV-Encoded Small RNAs, the EBERs: In Vitro Assays. Humana Press eBooks. 174. 297–310.
17.
Laing, Ken, Androulla Elia, Ian W. Jeffrey, et al.. (2002). In Vivo Effects of the Epstein–Barr Virus Small RNA EBER-1 on Protein Synthesis and Cell Growth Regulation. Virology. 297(2). 253–269. 22 indexed citations
18.
Clemens, Michael J. & Androulla Elia. (1997). The Double-Stranded RNA-Dependent Protein Kinase PKR: Structure and Function. Journal of Interferon & Cytokine Research. 17(9). 503–524. 510 indexed citations breakdown →
19.
Elia, Androulla, et al.. (1996). Regulation of the Double-stranded RNA-Dependent Protein Kinase PKR by RNAs Encoded by a Repeated Sequence in the Epstein-Barr Virus Genome. Nucleic Acids Research. 24(22). 4471–4478. 34 indexed citations
20.
Clemens, M J, Ken Laing, Ian W. Jeffrey, et al.. (1994). Regulation of the interferon-inducible eIF-2α protein kinase by small RNAs. Biochimie. 76(8). 770–778. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026